Chester County News and Community Website
NEWTOWN, PA — Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, announced the publication of a preclinical study …
Read More
HATFIELD, PA — AllerGenis, a predictive data analytics company specializing in the detection and management of life-threatening immune response disorders including food allergy, announced the publication of a peer-reviewed study entitled, “Accurate …
Read More HATFIELD, PA — AllerGenis, a predictive data analytics company specializing in the detection and management of life-threatening immune response disorders initially focused on food allergy, announced that the company’s chief scientific …
Read More
EXTON, PA — Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics, announced that it advanced its …
Read More
WASHINGTON, D.C. — The U.S. Department of Health and Human Services (HHS) is investing $150 million to increase access to COVID-19 monoclonal antibody therapeutic treatments for patients in vulnerable communities …
Read More
EXTON, PA — Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company that utilizes its human memory B cell platform to discover and develop first-in-class antibody therapeutics, announced that its discovery engine …
Read More EXTON, PA — Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics, announced the release of findings from …
Read MoreThe U.S. Food and Drug Administration recently approved Tecartus (brexucabtagene autoleucel), a cell-based gene therapy for treatment of adult patients diagnosed with mantle cell lymphoma (MCL) who have not responded …
Read More
Since the coronavirus (COVID-19) was first reported from Wuhan, China, in December 2019, the disease has been a dominating headline in media around the world.
Read More
CHEYNEY, PA — Navrogen, Inc., a biopharmaceutical company specialized in developing therapies for cancer and immune-related disorders, announced the opening of its R&D operations at the Cheyney University science center …
Read More